ロード中...
Long-term outcomes with nonmyeloablative HLA-identical related HCT using tacrolimus and MMF for GVHD prophylaxis
Nonmyeloablative allogeneic hematopoietic cell transplantation (HCT) from HLA-identical related donors using cyclosporine (CSP) and mycophenolate mofetil (MMF) for post-grafting immunosuppression is effective therapy for hematologic cancers. However, graft-vs-host-disease (GVHD) remains a major caus...
保存先:
| 出版年: | Transplant Cell Ther |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8035484/ https://ncbi.nlm.nih.gov/pubmed/33830025 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtct.2020.10.016 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|